Longitudinal Case #4: EXTRA NOTES

🌸 FULL MEDICATION HISTORY (Script-Ready Version)

(Cleaned, organized, grouped, and interpreted — no recommendations yet, just accurate history)

Random Facts:

• Has not tried Abx UTI prophylaxis (reminder allergic to SMX/TMP)

  • Has tried methenamine prophylaxis but was ineffective at reducint UTIs

  • Recently treated with etrapenem (due to ciprofloxacin allergy) for UTI episode 

  • No urine/C&S for most recent infection available

  • UTI unrelated to coitus 

  • Unclear if UTIs were cystitis or pyelonephritis (doesnt remember sx)

  • Hx of pseudomonas UTIs 

💊 1. Analgesics & Opioids

Tylenol #3 (Acetaminophen/Codeine/Caffeine)

• Dose: 2 tablets q4h PRN

• Dispense: 40 tablets every 2 weeks

• Indication: Pain + Headaches 

• Notes from patient: Uses regularly; essentially functioning as scheduled therapy.

• Last fill: April 10 2025 

Morphine IR 5 mg

• Dose: 1 tab q6h PRN

• Dispense: 30 tablet

  • (Usually takes 1 tab/day)

• Indication: Breakthrough pain (bladder pain); catheter changes  

  • Usually takes when doing catheter changes monthly + 2-3 days following procedure 

• Last Fill: Feb 11 2025

Morphine SR 15 mg

• Dose: 1 cap TID PRN

  • Usually 1 cap/day (daily)

• Dispense: 60 caps

• Indication: Chronic bladder pain (self-directed)

• Last Fill: Feb 11, 2025

Ketorolac 10 mg

• Dose: 1 tab BID PRN

• Indication: Severe pain flares

• Notes: Dispensed Feb 11 2025 (Emergency Department) 

Naproxen 500 mg

• Dose: 1 tab BID with food, PRN inflammation

• Indication: Pain, inflammation

• Last fill: March 23 2025

Cyclobenzaprine 10 mg

• Dose: 1 tab HS PRN

• Indication: Bladder spasms

• Notes: Patient reports poor bladder spasm relief.

• Dispensed: April 10, 2025

💥 2. Neuropathic / Central Pain Agents

Gabapentin 300 mg & 400 mg

• Dose: 1200 mg TID (300 mg x4 TID)

• History: Sometimes filled as 400 mg capsules

• Indication: Nerve pain/sciatica 

• Notes: Regular use; weekly blister.

• Last fill: April 9 2025

Duloxetine 60 mg

• Dose: 90 mg every morning

• Indication: anxiety/depression (mood)

• Form: Weekly blister pack

• Last fill: April 9 2025

🤢 3. Nausea & GI Agents

Nabilone 1 mg

• Dose: 2 mg TID

• Indication: Nausea + pain

• Notes: Patient reports effectiveness.

• Last fill: April 9, 2025

Ondansetron ODT 4 mg

• Dose: ½–1 tab PRN

• Indication: Nausea (Effective for her)

• Use: 1–2 times/week

• Last fill: Feb 12, 2025

Metoclopramide 5 mg

• Dose: 1 tab TID

• Indication: Headache associated Nausea

• Notes: Still taking; confirm reason.

• Last Fill: April 9 2025 (Daily dispense blister) 

Rabeprazole 20 mg

• Dose: 20 mg BID

• Indication: Acid reflux 

• Notes: Chronic PPI therapy → linked to low ferritin.

  • Patient confirms symptoms. well controlledare

• Last fill: April 9, 2025

Fosfomycin 3 g

• Use: 1 dose before monthly catheter changes

• Indication: Prophylaxis against UTI bacteria during catheter swap

• Last fill: Nov 6, 2024

🧠 4. Psychiatric Medications

Lorazepam 1 mg SL

• Dose: 1 tab SL daily PRN

• Quantity: 10 tabs/week

• Indication: Anxiety

• Last fill: March 7 2025

Hydroxyzine 10 mg

• Dose: 1–2 capsules HS PRN

• Indication: Insomnia associated with stress or fibromyalgia

• Use: 1–2 nights/week

• Last Fill: March 28, 2025

Vyvanse 60 mg

• Dose: 1 cap every morning

• Indication: Binge eating disorder, ADHD

• Notes: Regular weekly blister pack

• Last fill: April 9 2025

🫁 5. Migraine & Vestibular Medications

Propranolol 80 mg

• Dose: 80 mg BID

• Indication: Chronic migraine prophylaxis

• Notes: Daily dispense blister

• Last fill: April 9 2025

Sumatriptan 5 mg nasal spray

• Dose: 1 spray BID PRN

• Use: ~4 times/month

• Indication: Acute migraine

• Last fill: Feb 12, 2025

Sumatriptan 20 mg nasal spray

• Earlier fill Jan 2025

• Likely same indication

• Last fill: Jan 3 2025

Betahistine 16 mg

• Dose: 1 tab TID PRN

• Indication: Vertigo / vestibular symptoms

• Use: Occasional

• Last fill: Feb 11 2025

🚽 6. Bladder / Urology Medications

Hyoscine butylbromide 10 mg

• Dose: 1 tab q8h PRN (daily dispense)

• Indication: Bladder spasms

• Notes: Reports partial benefit (**need to keep this**)

  • Does not use often but would like to have it on hand

• Last fill: April 10 2025

Solifenacin 5 mg

• Dose: 1 daily (can increase to 10 mg)

• Status: Not filled since Dec 2024

• Notes: Effective but too expensive; patient stopped (“On and off”) 

• Currently prescribed —> significant improvement of bladder pain while using but cost is a barrier (so maybe thats why it was last filled in 2024) 

Colchicine 0.6 mg

• Dose: 1 tab daily

• Original indication: Knee pain

• Notes: No longer clinically needed

  • Patient confirms she does not have gout or periarditis and believe it was prescribed for knee pain but knee pain is no longer an issue 

• Last fill: April 9 2025

OnabotulinumtoxinA (Botox)

• Dose: 100 units intravesical

• Last fill: Jan 2025

• Indication: OAB / bladder pain

• History: Received injections 2022 + 2025

👃 7. Respiratory / Nasal Steroids

Beclomethasone 50 mcg

• Dose: 1 spray each nostril daily

• Indication: Allergic rhinitis

• Last fill: Feb 28 20255

Mometasone 50 mcg

• Dose: 1 spray each nostril daily

• Indication: Allergic rhinitis

• Last fill: Feb 28 2025

Fluticasone 50 mcg

• Dose: Apply HS

• Notes: Possibly for dermatitis or nose

• Last fill: Feb 28 20255

🦠 8. Anti-Infectives

Mupirocin ointment

• Use: TID

• Indication: MRSA decolonization / skin lesions

• Last fill: March 31, 2025

• DISCONTINUED

Fusidic acid cream

• Use: TID

• Indication: Skin infections

• Last fill: Feb 28 2025

  • Probably no longer taking?

Cephalexin 500 mg

• Use: 1 tab QID until finished

• Indication: UTI or soft tissue infection

• Last fill: Jan 17, 2025

  • Probably no longer taking?

Fluconazole 50 mg

• Dose: 150 mg weekly (3 tabs)

• Indication: Antifungal prophylaxis or recurrent infections

• Last fill: Jan 10, 2025

  • Probably no longer taking?

Nystatin suspension

• Dose: 1–2 mL QID

• Indication: Oral candidiasis

• Last Filled: Dec13 2024 

  • Probably no longer taking?

🧴 9. Dermatology

Tretinoin 0.025% cream

• Dose: Apply HS

• Last fill: Feb 28 2025

Tretinoin 0.04% microspheres

• Dose: Apply HS

• Last fill: Feb 28 2025

Compounded Phenazopyridine (Pyridium)

• Dose: 2 caps TID PRN

• Indication: Severe bladder pain

• Notes: Very expensive; poor coverage → affects adherence

  • Helped but too expensive and not covered by Pharmacare

• Last fill: Dec 23 2024

• Also given in ED Feb 8 2025

🧘 10. Other

Baclofen

• Two forms:

  • 2 mg/mL ampule

  • 10 mg tablets

• Indication: Muscle spasm / pelvic pain?

• Notes: Use unclear; needs clarification.

• Last fill: Feb 1 2025 / Jan 10 2025

  • “Dispense every three days (likely DCd at this point because that was the last dispense) 

BPMH Notes

• Patient reports:

  • No OTC/NHPs

  • No additional meds beyond those listed

  • On many meds PRN but uses many of them regularly

  • Trialed oxybutynin in the past for 2 months but discontinued due to lack of effect

🌸 Immunization Record — Clinical Summary (for Case Workup)

(Extracted from Provincial Immunization Registry)

✔ Completed Vaccinations

COVID-19 (Moderna Spikevax)

• Dose 1: Mar 18, 2021

• Dose 2: Jun 09, 2021

Hepatitis A

• Dose 1: Jan 15, 2016

• Dose 2: Mar 05, 2018
  → Complete series

Hepatitis B

• Dose 1: Apr 30, 2019

• Dose 2: Jun 04, 2019

• Dose 3: Nov 05, 2019
  → Complete series

Influenza (inactivated)

• 2021 Dec 08

• 2023 Oct 26

• 2024 Oct 20
  → Up to date on annual flu vaccines

Td (Tetanus/Diphtheria)

• Jan 01, 2012
  → Booster overdue

✔ Vaccinations Due / Overdue

✔ Adverse events following vaccination

• None reported

✔ Special Considerations / Risk Factors

• No immunization deferrals

• No flagged risk factors
  → Important because many chronic pain or bladder patients may be immunosuppressed — she is not.

🌸 How this fits into your case presentation

Under Social History or Preventive Care:

You will say something like:

“Her immunizations are mostly up to date. She has completed her Hepatitis A and B series and receives annual influenza vaccinations. Her last tetanus booster was in 2012, so she is due for a Td/Tdap update. She has received two COVID-19 vaccinations but is due for her next booster in October 2025. There are no documented adverse vaccine reactions.”

Why this matters clinically

• Recurrent ED visits + frequent catheter manipulations → ensure tetanus protection

• Chronic bladder pain but not immunocompromised → vaccinations remain standard

• Preventive care is part of comprehensive primary care workup

✅ Consult Note #1 — Pelvic Floor Physiotherapy (April 2024 onward)

(Organized + interpreted for integration into your case workup)

Source Summary (your note rewritten clearly):

• Referred for pelvic floor physiotherapy starting April 2024.

• Main complaints: bladder spasms + bladder pain.

• Symptoms significantly impact quality of life — prevents swimming and playing in a band.

• Initial pelvic floor exam:

  • Poor awareness

  • Poor coordination

  • Poor contraction

  • Poor relaxation

• Improvement over time:

  • Pelvic floor function improved ~50%

  • Catheter changes became easier

  • BUT bladder spasms did not significantly improve.

• Physiotherapist recommends continuing therapy and possibly adding:

  • Pelvic floor work

  • Electrical muscle stimulation (used for OAB/bladder pain)

• Requests physician to provide a re-referral.

🌸 How I will integrate this into the full workup later

HPI / Bladder Pain Narrative

• Chronic pelvic/bladder pain since at least 2024.

• Severe functional impairment (unable to swim or participate in music).

• Pelvic floor dysfunction confirmed by physiotherapy.

• Bladder spasms resistant to pelvic floor improvement.

Past Medical History

• Pelvic floor dysfunction (documented + partially responsive to treatment).

Interventions Tried

• Pelvic floor physiotherapy (partial improvement).

• Catheter changes easier after therapy → suggests pelvic floor hypertonicity previously.

• No relief of bladder spasms → supportive of interstitial cystitis/bladder pain syndrome, not purely mechanical.

Future/Plan-Relevant Points

• Could justify:

  • Considering electrical stimulation trial

  • Continuing physiotherapy

  • Assessing for central sensitization

  • Evaluating bladder spasm treatment options (solifenacin, pregabalin, etc.)

🌸 ED Visit — Feb 8, 2025: Clean Clinical Summary (For Case Build)

(We will integrate this into your HPI chronologically once you send the rest)

1. Reason for ED Visit

Acute worsening of chronic bladder spasms
2 days after intravesical Botox injection + suprapubic catheter change (Feb 6, 2025)

Symptoms:

• RLQ abdominal pain

• Increased bladder/perineal pain

• Constant but fluctuating

• Nausea (no vomiting)

• No fever

• No bowel movement since Thursday

• Catheter draining well

Pain severity:

• Hydromorph Contin 15 mg TID + hydromorphone IR 5 mg q4–6h — 4 tablets in 24 hours

• T3 1 tab q6h

• Cyclobenzaprine + ondansetron

• Not using NSAIDs at home

2. ED Physician Impression

Key points:

• Bladder spasm flare attributed to recent procedure

• Urine dip shows trace leukocytes but clinically inconsistent with infection

• Follow care plan: culture sent, ID must review before starting antibiotics

• Pain improved significantly in ED → discharged with standard return precautions

3. Past Medical History (Extracted)

Already consistent with your previous list, but confirming:

• Interstitial cystitis / chronic bladder pain syndrome

• Overactive bladder

• Chronic UTIs (on suprapubic catheter)

• Urinary retention

• Chronic pelvic pain

• Depression

• Anxiety

• Borderline personality disorder

• History of self-harm

• Chronic migraines

• Frequent respiratory infections

• Morbid obesity

• MRSA carrier

• History of lumbar puncture → opening pressure 22.5 (2020)

• Chronic pelvic floor dysfunction

4. Surgical / Procedural History (Updated)

Recent

• Feb 6, 2025 → Cystoscopy + 100U intravesical Botox + SPC exchange
  Past

• Nov 2024 → EGD + colonoscopy

• Apr 2023 → Hysteroscopy + D&C + SPC change

• Dec 2022 → Prior Botox + initial SPC insertion

• Right ankle surgeries ×3

• Cholecystectomy

• Multiple SPC tract dilations

5. Vitals (Day of Visit)

• T 36.7°C

• HR 55

• RR 16

• BP 107/65

• SpO₂ 98%

Interpretation:

• Afebrile

• No tachycardia

• No respiratory compromise despite high CNS-depressant burden

• No hemodynamic instability
  → Supports non-infectious etiology for pain.

6. Physical Exam (Summarized & Interpreted)

• Appears well, no distress

• Lungs: normal

• Heart: normal

• Abdomen: soft, diffuse lower abdominal tenderness (RLQ & LLQ), no guarding/peritonitis

• Perineum/labia: normal, no rash or erythema
  → Findings consistent with bladder spasm flare, not UTI or peritonitis.

7. Lab Results

CBC

Why it matters:
→ Again supports no systemic infection.

Chemistry / Renal

Why it matters:

• No kidney dysfunction → infection not affecting kidneys

• CO₂ mild elevation (chronic pain hyperventilation or nausea)

Inflammation

Pattern:

• Too low for acute pyelonephritis (typically >40–50)

• Consistent with chronic bladder inflammation + post-procedure irritation

Urinalysis

Overall:
UDS not convincing for UTI — false positives common in catheter users.

8. ED Medications Administered

• Ketorolac 30 mg IM

• Morphine 5 mg SQ

• Ondansetron 4 mg ODT

• Phenazopyridine 200 mg PO
  → Pain improved dramatically with this regimen.

9. Allergies (as documented in this visit)

• Latex — rash

• Diamox — severe vomiting

• Ciprofloxacin — hives

• Macrobid — rash, tachycardia

• Septra — itching

• Tramacet — hives

• Clindamycin — dizziness/vomiting

• Clindamycin + benzoyl peroxide — swelling

• Macrolides — arrhythmia, hives

• Topiramate — rash

• Tramadol — rash

We will merge this with your full allergy list later.

🌸 ED Visit — March 11, 2025: Clean Clinical Summary (UTI + IV Ertapenem Reassessment)

1. Reason for ED Visit

Here for Day 7 reassessment of IV ertapenem course for known Klebsiella UTI per ID plan.

Important context:

• She is a well-known frequent ED return related to bladder pain + SPC

• Missed 1 dose the day before → here for catch-up dose

• ID recommended 7–10 days total; ED extended to 10 days because of missed dose

Symptoms today:

• Feeling “a bit better”

• Some mild diarrhea (likely from antibiotic or baseline IBS-like symptoms)

• No fever

• No systemic symptoms reported

2. ED Physician Impression

Key points:

• They are not questioning the diagnosis here because ID already confirmed Klebsiella on March 4–6

• No signs requiring further ED intervention

• Mild diarrhea but tolerating therapy

• Affect “flatter” than usual → possibly pain/fatigue/medications

3. Relevant Past Medical History (Reconfirmed)

Same as prior note; ED reconfirms:

• Chronic UTIs (Klebsiella predominant)

• Suprapubic catheter → chronic colonization

• Chronic bladder spasms

• Psychiatric comorbidities: anxiety, depression, BPD

• Chronic migraines

• Morbid obesity

• MRSA carrier

• History of self-harm

• Lumbar puncture elevated opening pressure (intracranial hypertension history?)

• Chronic urinary retention

4. Vitals (Mar 11, 2025)

• T 36.7 °C

• HR 65

• RR 16

• BP 106/55

• SpO₂ 95%

Interpretation:

• No fever

• No tachycardia

• Normal respiratory status
  → Again supports responding to therapy, not worsening infection.

5. Physical Exam Summary

• Looks well

• Flatter affect than baseline

• No acute distress

• No unstable findings

Fits with:

• Partially treated UTI

• Also her baseline chronic pain picture

6. Medications Given in ED

• Ertapenem 1 g IV (continuing treatment)

• Ketorolac 15 mg IV (pain)

7. Allergies (Reconfirmed)

Same major ones appear again:

• Latex

• Acetazolamide (Diamox)

• Ciprofloxacin

• Nitrofurantoin (Macrobid)

• TMP-SMX (Septra)

• Clindamycin

• Macrolides

• Topiramate

• Tramadol/Tramacet

This ED note further reinforces her extreme antibiotic limitations for UTIs.

8. Diagnostic Data

• No new labs shown in the note (they sent labs but results were to be reviewed next day).

• However, clinically she looks better → appropriate progress.

🌼 How This Will Fit into Your Final HPI Timeline Later

March 4–6, 2025:

• ID diagnosed Klebsiella UTI

• Started on IV ertapenem for 7–10 days

March 11, 2025:

• ED follow-up after missed dose

• Continues IV ertapenem

• Mild diarrhea but improving urinary symptoms

• No systemic infection features

• Plan extended to 10 days

This builds a pattern:

• RL has true UTIs only occasionally, usually Klebsiella

• Responds to IV carbapenems

• But most ED visits are not true UTIs — they’re bladder pain flares
  → This supports your Part 2 infographic topic PERFECTLY.

🌸 How This Fits Into DTPs Later

1. Safety

• Repeated IV antibiotics → C. diff risk

• Carbapenem exposure → antimicrobial resistance risk

• Severe antibiotic allergy profile → limited future options

2. Effectiveness

• Recurrent “treated UTIs” often may not be UTIs → inappropriate antibiotic use

3. Indication

• Need strong differentiation between:

  • True UTI

  • BPS flare

  • Catheter irritation

4. Adherence

• Missed dose → not ideal for severe UTI

• Weekly/daily dispenses → adherence barriers

🌸 ED Visit — March 12, 2025: Clean Clinical Summary (Day 8 Ertapenem + Diarrhea Concern)

1. Reason for Visit

Patient presents for Day 8 of IV ertapenem for a confirmed Klebsiella complicated UTI.

Symptoms today:

• Ongoing lower abdominal pain/cramping

• Diarrhea (non-bloody) → patient worried about C. difficile

• Took morphine overnight, helpful

• No morphine used today

• No fever

• Reports feeling “better overall”

Note: This is now the third consecutive ED visit related to this same UTI treatment course.

2. ED Physician Impression / Plan

1. Complicated UTI — continue ertapenem

• Labs from yesterday (Mar 11) reviewed:

  • Potassium 5.3 (mildly high)

  • CRP 4 mg/L (very low → strongly against active systemic infection)

• No changes to treatment

• Continue ertapenem until March 14

• Return the next day for further doses

2. Diarrhea

• Suspected antibiotic-associated diarrhea

• Non-bloody

• Outpatient C. diff test requisition provided

• No concerning dehydration or systemic symptoms

3. Detailed History Extracted

• This physician knows her well (“known to myself”)

• This is Day 2 of this physician’s encounters but Day 8 of ertapenem course

• Chronic bladder spasms complicate picture

• Her pain improved enough that she did not need morphine today

• No red flags

4. Vitals (Mar 12, 2025)

• T 36.7 °C

• HR 71

• RR 17

• BP 94/65 (soft but OK; she is often low-normal BP)

• SpO₂ 97%

Interpretation:

• Afebrile

• Hemodynamically stable

• No respiratory compromise

• Consistent with improving infection

5. Physical Exam

• Appears well

• No distress

• Abdomen: soft, obese, mild suprapubic discomfort only

• No guarding

• No rebound

• Good perfusion
  → No signs of peritonitis, acute abdomen, or severe infection
  → Fits with improving UTI & diarrhea likely antibiotic-associated

6. Relevant Lab Data (from Mar 11, but referenced in this note)

Electrolytes

• K 5.3 mmol/L ↑ mild
  → usually transient, likely not dangerous
  → no renal impairment

Inflammation

• CRP 4 mg/L
  → almost normal
  → absolutely not consistent with ongoing/acute UTI
  → supports improving course

(No CBC results shown in this note; likely normal or unchanged.)

7. Procedure & Past History (same as prior notes)

No new surgeries or PMH added.

8. ED Medications

• Ertapenem 1 g IV

• Ketorolac 15 mg IV

9. Allergies (Reconfirmed Again)

No changes — same severe antimicrobial allergy profile.

🌸 What This Adds to Her Timeline

This note emphasizes:

✔ She has true UTIs sometimes — but they behave predictably:

• Klebsiella, occasionally pseudomonas in the past

• She clinically improves with carbapenems

• Doesn’t develop fevers, leukocytosis, or high CRP

• Symptoms improve gradually

✔ Her diarrhea is probably antibiotic-associated, not C. diff:

• Non-bloody

• CRP low

• No abdominal findings

• She is not systemically sick

✔ Important for Part 2 infographic

This is PERFECT evidence for your SDM topic:
How to tell a UTI from a bladder pain flare.

This ED note shows:

• Pain from bladder spasm vs pain from UTI often look similar

• Infection indicators (fever, high CRP, high WBC) are absent

• Symptoms improved without any extra interventions

• Diarrhea = a side effect of treatment, not infection worsening

✔ Important for DTPs

• Risk of C. diff from frequent antibiotics

• Reinforces the need for a UTI action plan

• Reinforces need for a decision aid

• Shows how often she receives antibiotics even when not always necessary

• Shows the danger of broad-spectrum exposure

• Highlights antibiotic stewardship needs

🌸 General Referral Form — Clinical Summary (Polypharmacy & Bladder Pain Referral)

Reason for Referral (as written on the form)

• Polypharmacy

• Complex bladder pain

• UTI prophylaxis

• Bladder instillations for pain

This is HUGE because it clearly states the exact issues they want addressed — which become natural priority DTPs for your presentation.

🌼 What This Tells Us Clinically

✔ 1. Polypharmacy is officially documented as a concern

This isn’t just something we noticed — clinicians are formally worried about it.

This supports making:

• Safety your first priority category

• A clear deprescribing plan for:

  • Opioids

  • Cyclobenzaprine

  • Nabilone

  • Hydroxyzine

  • Benzodiazepines

  • Duplicate/ineffective bladder meds

  • Unnecessary colchicine

  • Unnecessary B12 supplements

AND it gives full justification for addressing it in the first visit.

✔ 2. Complex bladder pain is a key issue

This aligns with:

• Her diagnosis of Interstitial Cystitis / Bladder Pain Syndrome

• Chronic suprapubic catheter pain

• Pelvic floor dysfunction

• High ED usage

• Recent Botox injections

• Chronic bladder spasm refractory to treatment

It validates that bladder pain is one of her core clinical problems, not secondary.

✔ 3. UTI prophylaxis is being directly requested

This confirms:

• She has a history of true UTIs (Klebsiella + Pseudomonas)

• Providers want a long-term plan

• Antibiotic allergies complicate treatment

• There’s interest in non-antibiotic prophylaxis

  • Methenamine

  • Cranberry PAC

  • Vaginal estrogen (not for her though; age 37 might still be appropriate depending on cycles)

  • Immunoprophylaxis

  • Behavioral strategies

  • Catheter hygiene optimization

This also ties PERFECTLY into your SDM infographic topic.

✔ 4. Bladder Instillations Requested

This implies:

• Providers believe her pain is inflammatory, not infectious

• Instillation options would include:

  • Lidocaine/heparin

  • Sodium bicarbonate

  • DMSO

  • Hyaluronic acid

  • Chondroitin sulfate

This reinforces the concept of chronic non-infectious bladder pain and the need to differentiate it from UTIs.

🌸 How This Will Integrate Into Your Final Workup

Under “Reason for Referral” / HPI:

You’ll say something like:

“She was referred specifically for assistance with polypharmacy management, chronic bladder pain, evaluation for UTI prophylaxis options, and consideration of bladder instillation therapy.”

Under “Assessment” (Problem List):

You can clearly list:

1. Polypharmacy with high-risk CNS depressant stacking

2. Chronic bladder pain / BPS with suprapubic catheter

3. Recurrent UTIs (Klebsiella), complicated by severe antibiotic allergy profile

4. Need for long-term UTI prophylaxis strategy

5. Consideration of bladder instillations

Under “Priority DTPs” (Professor emphasized this):

This referral confirms the top problems your professors expect you to focus on.

Priority order (safety → effectiveness → indication → adherence):

1. Safety: CNS depressant polypharmacy

2. Safety: frequent broad-spectrum antibiotics → C. diff risk

3. Effectiveness: bladder pain poorly controlled

4. Effectiveness: unclear UTI prophylaxis strategy

5. Indication: unnecessary colchicine/B12/duplicate therapies

6. Adherence: cost barriers + complex dosing schedule

This referral directly justifies this ordering.

🌸 ED Note – March 24, 2025: Flank Pain Episode

Why this encounter matters:
This is a perfect example of how her bladder pain + catheter + menstrual cycle + chronic inflammation create pseudo-infectious symptoms that LOOK like pyelonephritis or obstructing stone — but labs don’t support infection.

This strongly supports:

✔ Chronic bladder pain syndrome

✔ High ED utilization

✔ Difficulty distinguishing UTI vs flare

✔ The clinical need for patient decision aids (your infographic fits PERFECTLY)

✔ High opioid use because pain is severe and poorly controlled

✔ Repeated unnecessary cultures and imaging

🌼 Clinical Summary of This Encounter

Chief complaint:

• Lower abdominal pain → now radiating to right flank

• Pain comes in waves

• Heavy menstrual flow today

• “Cloudy urine,” bladder spasms

• Took naproxen 1500h

• Sweaty but unsure about fever

• Pain different from usual bladder spasm pain → triggered ED visit

🌸 Assessment from ED

✨ Vitals normal

• Afebrile (36.7)

• HR stable

• BP normal

• SpO2 98%

✨ Labs

• WBC 10.9 (upper-normal, not convincing for infection)

• CRP 14.4 mg/L (mild elevation)
  — Nonspecific, could be menstrual inflammation, bladder pain flare, or stone

• UA:

  • Moderate blood

  • Small leukocytes

  • Nitrite negative

  • NO protein

  • NO ketones

This UA screams stone, catheter irritation, or flare, NOT UTI.

✨ Imaging

• KUB X-ray normal

• No gross stone visible, but ultrasound ordered for higher sensitivity

✨ Treatment

• Given ketorolac IM

• Sent home on her own morphine

• Culture ordered but cancelled as duplicate

🌟 Clinical Significance

This note adds several crucial findings for your workup:

1. Her bladder pain is not always infectious

Repeated ED visits with:

• Normal vitals

• Mild leukocytes

• Hematuria +/-

• Pain ≠ infection

Supports chronic bladder/pelvic pain syndrome + catheter-related irritation.

2. Chronic hematuria → stone suspicion

She has intermittent hematuria (seen on other UAs too).
This supports:

• Possible stones

• Catheter irritation

• Chronic bladder inflammation

3. Menstrual cycle exacerbates bladder/pelvic pain

Pain peaked on day 1 of period.
Classic in chronic pelvic pain, BPS, and pelvic floor dysfunction.

4. MASSIVE clinical justification for your decision aid

This encounter is basically BEGGING for an educational tool about:

Your infographic becomes even more clinically grounded.

5. Opioid reliance continues

She was told to use “morphine at home.”
High CNS/sedation risk.
Polypharmacy remains a top priority.

🌼 How This Will Fit into Your Case Presentation

Under HPI / Clinical Pattern:

• “Repeated ED presentations for flank/bladder pain with stable vitals and non-specific labs — consistent with chronic suprapubic catheter irritation, pelvic pain, and bladder pain syndrome rather than recurrent UTI.”

Under Problem List:

1. Chronic bladder/pelvic pain with episodic severe flares

2. Recurrent ED visits due to unclear distinction between UTI vs pain flare

3. Chronic low-level hematuria

4. Recurrent unnecessary cultures

5. High opioid reliance for pain crises

6. Stressors around menstruation worsening symptoms

Under DTPs:

• Effectiveness Issue: Pain poorly controlled despite high-intensity regimen

• Safety Issue: Recurrent exposure to NSAIDs + opioids + cyclobenzaprine

• Safety Issue: Over-evaluation for infection → unnecessary cultures/antibiotics

• Effectiveness Need: Clear care pathway + prophylaxis + flare plan

Under SDM Opportunities:

• What to do during a flare

• When to seek ED

• When antibiotics are appropriate or not

• Pain plan adjustments

🌸 A. MOST RECENT LABS (March 11, 2025)

This is the set we will use for the current case.

✔ CBC — NORMAL

• WBC 7.4

• Hgb 125

• Platelets 218

• MPV is mildly decreased at 9.0. Low MPV reflects smaller, older platelets and is often seen with chronic inflammation, chronic pain, and iron deficiency—all of which this patient has. Platelet count is normal, so no action is needed.”

• No leukocytosis

• No anemia

• No thrombocytosis or thrombocytopenia

➡ Interpretation:
No acute infection, no anemia of chronic disease, no major hematologic abnormalities.

✔ Chemistry — Almost Entirely Normal EXCEPT:

1) Potassium 5.3 (High) (RR = 3.5-5.0)

This is mild hyperkalemia.

Likely causes in this patient:

• NSAID use? (she was not taking them consistently)

• Mild dehydration

• Lab variation

• Pain/stress

• Muscle relaxants rarely

• Opioids don’t cause hyperK

• Not from kidney disease (Cr 65, eGFR 105 = excellent)

➡ Clinically: very mild, not concerning, but worth monitoring since she has polypharmacy.

2) CO₂ (bicarbonate proxy) = 32 (High) (RR = 22-31) 

This suggests:

• Mild metabolic alkalosis OR

• Chronic compensation for respiratory acidosis (COPD style — but she does NOT have COPD)

Most likely:
Chronic hyperventilation/pain response, frequent vomiting/nausea episodes, OR unrelated variation.

Not dangerous.

3) CRP 4.0 (slightly elevated) (RR < 3.1) 

Interpretation from CRP chart:

In this patient →
She is on IV ertapenem at the time and improving.
This CRP is consistent with resolving infection.

Not highly elevated.

✔ Renal

• Creatinine 65

• eGFR 105
  ➡ Perfect kidney function (important for methenamine, NSAIDs, opioids, and antibiotic choices)

🌸 B. Previous Labs (Trend Summary)

This is where the ✨clinical thinking✨ gets juicy.

Across ALL previous labs from 2024–2025:

✔ 1) CBC is always normal

This means:

• No chronic infection

• No untreated anemia

• No immunocompromise

• No marrow suppression

💗 Important for polypharmacy review (many of her meds cause sedation but not blood issues).

✔ 2) Creatinine ALWAYS normal (60–78)

→ She has stable kidney function
→ She is a good candidate for methenamine if we propose it
→ Long-term antibiotics won’t be nephrotoxic for her
→ Opioids are safe from a renal perspective

✔ 3) CRP fluctuates:

• Jan 2025 = 5.3

• Mar 4 = CRP 19

• Mar 11 = CRP 4

• Mar 24 = CRP 14

• Apr 1 = CRP 11

• Apr 18 = CRP 23

This pattern = chronic low-grade inflammation, typical of:

• Chronic bladder pain

• Suprapubic catheter irritation

• Recurrent colonization / mild infection

• Chronic pain syndromes in general

• Recurrent urologic procedures

• Occasional true UTI episodes

• Chronic inflammatory conditions

But importantly, not high enough to confirm complicated systemic infection.

This supports our narrative:
She frequently presents to ED with pain flares + mild markers but not true sepsis.

✔ 4) Ferritin repeatedly low (20–21)

The guideline says:

YES bestie!!
She is iron deficient.
This explains:

• fatigue

• pain amplification

• poor healing

• possibly perpetuating chronic symptoms

✨ This is a GREAT DTP to include in polypharmacy assessment. ✨

✔ 5) Vitamin B12 high (1061)

Likely from supplementation (common).
Not clinically concerning.

🌸 C. What These Labs Mean for Your Case Workup

✨ 1. She does NOT have major infection markers

Even during “UTI” ED visits:

• WBC normal

• CRP mildly elevated

• No fevers

• No hypotension
  → This supports:
  She often has bladder pain flares mistaken for UTIs.

This is GOLD for your case rationale.

✨ **2. Her kidneys are great →

She can use methenamine, NSAIDs short-term, and most bladder therapies.**

✨ **3. She has real chronic inflammation →

Bladder instillations are appropriate to consider**
(because they target urothelial lining inflammation)

✨ **4. No anemia →

But iron deficiency is emerging**
(another DTP!)